Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
CERo Therapeutics Holdings Inc (NASDAQ:CERO) shares are trading higher Tuesday after the company received U.S. Food and Drug Administration (FDA) Orphan Drug Designation for CER-1236.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果